1-2 of 2
Sara Di Giusto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BCR-ABL1 Levels at First Month after TKI Discontinuation Predict Subsequent Maintenance of Treatment-Free Remission: A Study from the "Gruppo Triveneto LMC"

Sara Di Giusto, PhD, Eleonora Toffoletti, MD, Massimiliano Bonifacio, MD, Gianni Binotto, MD, Maria Cristina Miggiano, MD, Elisabetta Calistri, MD, Manuela Stulle, MD, Anna Ermacora, MD, Rossella Stella, MD, Luigi Scaffidi, MD, Fabio D'Amore, MD, Giorgia Scotton, MD, Giovanna De Matteis, PhD, Roberta Bertorelle, PhD, Renato Fanin, MD, Mauro Krampera, MD PhD, Gianpietro Semenzato, MD, Daniela Damiani, MD, Mario Tiribelli, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-135968
Published: 2020
Journal Articles

ABCG2 but Not ABCB1 RNA Levels at Diagnosis and during Treatment Correlates with Response to Imatinib and 2G-Tkis Front-Line Therapy in Chronic Phase CML Patients

Mario Tiribelli, MD, Sara Di Giusto, Eleonora Toffoletti, Davide Griguolo, Domenico Penna, Giorgia Maccari, Marta Medeot, Renato Fanin, Daniela Damiani
Journal: Blood
Blood (2017) 130 (Supplement 1): 1614.
https://doi.org/10.1182/blood.V130.Suppl_1.1614.1614
Published: 2017